Plant ID: NPO4138
Plant Latin Name: Betula platyphylla
Taxonomy Genus: Betula
Taxonomy Family: Betulaceae
NCBI TaxonomyDB:
78630
Plant-of-the-World-Online:
n.a.
Antifungal; Antiinflammatory; Antiseborrheic; Cancer; Tonic
South Korea; China
ALPL; | |
CA2; CA12; CA7; | |
NR1H4; | |
NFKB1; | |
SLC5A2; SLC5A1; SLC5A4; | |
FABP4; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
SLC superfamily of solute carriers | SLC5A2 | Sodium/glucose cotransporter 2 | P31639 | CHEMBL3884 |
SLC superfamily of solute carriers | SLC5A1 | Sodium/glucose cotransporter 1 | P13866 | CHEMBL4979 |
SLC superfamily of solute carriers | SLC5A4 | Low affinity sodium-glucose cotransporter | Q9NY91 | CHEMBL1770047 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005215; transporter activity | GO:0005412; glucose:sodium symporter activity | 1.997E-09 | 4.348E-05 | SLC5A1, SLC5A2, SLC5A4 |
BP | Unclassified; | GO:0035428; hexose transmembrane transport | 1.531E-07 | 4.762E-04 | SLC5A1, SLC5A2, SLC5A4 |
BP | GO:0051179; localization | GO:1904659; glucose transmembrane transport | 1.531E-07 | 4.762E-04 | SLC5A1, SLC5A2, SLC5A4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 4.532E-08 | 4.762E-04 | CA12, CA2, CA7 |
BP | GO:0051179; localization | GO:0006811; ion transport | 6.366E-07 | 1.212E-03 | CA12, CA2, CA7, NR1H4, SLC5A1, SLC5A2, SLC5A4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 7.070E-07 | 1.212E-03 | CA12, CA2, CA7 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 7.235E-07 | 1.212E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.309E-06 | 1.900E-03 | CA12, CA2, CA7 |
BP | Unclassified; | GO:0015758; glucose transport | 1.499E-06 | 1.920E-03 | SLC5A1, SLC5A2, SLC5A4 |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 1.083E-05 | 9.827E-03 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 6.098E-08 | 3.903E-06 | CA12, CA2, CA7 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 5.054E-06 | 1.617E-04 | CA2, NR1H4, SLC5A1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | SLC5A4; SLC5A1; SLC5A2; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; |
Q00-Q99: Congenital malformations, deformations and chromosomal abnormalities | Genetic disease | Q00-Q99 | ALPL; |
NA: NA | Edema | NA | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 1 diabetes | E10 | SLC5A2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; SLC5A4; SLC5A1; SLC5A2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 1/2 diabetes | E08-E13 | SLC5A4; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
K00-K95: Diseases of the digestive system | Liver disease | K70-K77 | SLC5A2; |
C00-D49: Neoplasms | Colon cancer | C50 | ALPL; |